Investor Overview

Merus discovers and develops differentiated therapeutics aimed at substantially prolonging the lives of cancer patients. It is our strategy to use the power of bispecific antibody engineering and advanced screening technologies to develop biopharmaceuticals that engage the power of the immune system to kill tumor cells.

Summary Share Price

NASDAQ: MRUS0.319.12
Data provided by Nasdaq. Minimum 15 minutes delayed.

Upcoming Events

Wednesday, May 24, 2017
 8:00 a.m. CET
Annual General Meeting of Shareholders

Corporate Presentation

March Investor Presentation - PDF March Investor Presentation

RSS FeedsFinancial Tear SheetE-mail PagePrint PageE-mail Alerts